BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28434325)

  • 21. Merging extracellular domains: fold prediction for laminin G-like and amino-terminal thrombospondin-like modules based on homology to pentraxins.
    Beckmann G; Hanke J; Bork P; Reich JG
    J Mol Biol; 1998 Feb; 275(5):725-30. PubMed ID: 9480764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long pentraxin PTX3 in vascular pathology.
    Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
    Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide binding specificity of the chaperone calreticulin.
    Sandhu N; Duus K; Jørgensen CS; Hansen PR; Bruun SW; Pedersen LØ; Højrup P; Houen G
    Biochim Biophys Acta; 2007 Jun; 1774(6):701-13. PubMed ID: 17499031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid accomplices and enforcers.
    Alexandrescu AT
    Protein Sci; 2005 Jan; 14(1):1-12. PubMed ID: 15576561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?
    Thambisetty M
    Biomark Med; 2010 Dec; 4(6):831-4. PubMed ID: 21133702
    [No Abstract]   [Full Text] [Related]  

  • 26. Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils.
    Garvey M; Ecroyd H; Ray NJ; Gerrard JA; Carver JA
    Biomolecules; 2017 Sep; 7(3):. PubMed ID: 28895938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation: An innate response.
    McCarthy N
    Nat Rev Cancer; 2015 Apr; 15(4):197. PubMed ID: 25740422
    [No Abstract]   [Full Text] [Related]  

  • 28. Pentraxin-3.
    Akaike M
    Circ J; 2014; 78(1):65-6. PubMed ID: 24284958
    [No Abstract]   [Full Text] [Related]  

  • 29. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human serum amyloid P component is a single uncomplexed pentamer in whole serum.
    Hutchinson WL; Hohenester E; Pepys MB
    Mol Med; 2000 Jun; 6(6):482-93. PubMed ID: 10972085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentraxin 3 as a new biomarker of diastolic dysfunction.
    Liu Q; Tu T; Bai Z; Zhou S
    Int J Cardiol; 2011 Oct; 152(1):106-7. PubMed ID: 21855152
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased serum pentraxin-3 levels; a novel cardiovascular marker.
    Varol E
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):296-8. PubMed ID: 23760116
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum pentraxin 3 concentrations in neonates.
    Lannergård A; Rosenström F; Normann E; Larsson A
    Ups J Med Sci; 2014 Mar; 119(1):62-4. PubMed ID: 24438192
    [No Abstract]   [Full Text] [Related]  

  • 34. Pentraxin 3 innately preps damaged tissue for wound healing.
    Rua R; McGavern DB
    J Exp Med; 2015 Jun; 212(6):829. PubMed ID: 26034115
    [No Abstract]   [Full Text] [Related]  

  • 35. Childhood obesity, metabolic syndrome and Pentraxin-3.
    Menon PS
    Indian J Pediatr; 2015 Jan; 82(1):3-4. PubMed ID: 25502797
    [No Abstract]   [Full Text] [Related]  

  • 36. Arterial stiffness and pentraxin 3 levels in obese patients.
    Balta S; Kurtoglu E; Ozturk C; Demırkol S; Demır M
    Am J Hypertens; 2014 Jun; 27(6):881. PubMed ID: 24610886
    [No Abstract]   [Full Text] [Related]  

  • 37. Developing column material for the separation of serum amyloid P and C reactive protein from biological sources.
    Ersöz A; Ünlüer ÖB; Dönmez G; Hür D; Say RD
    Biomed Chromatogr; 2014 Oct; 28(10):1345-51. PubMed ID: 24827758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules.
    Gout E; Moriscot C; Doni A; Dumestre-Pérard C; Lacroix M; Pérard J; Schoehn G; Mantovani A; Arlaud GJ; Thielens NM
    J Immunol; 2011 May; 186(10):5815-22. PubMed ID: 21490156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of pentraxin-3 in POEMS syndrome.
    Agilli M; Aydin FN
    J Neuroimmunol; 2015 Jan; 278():136. PubMed ID: 25595262
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to "arterial stiffness and pentraxin 3 levels in obese patients".
    Miyaki A; Maeda S
    Am J Hypertens; 2014 Jun; 27(6):882. PubMed ID: 24610887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.